Mei Lu

发表

PERMUTATION TESTS AND OTHER TEST STATISTICS FOR ILL-BEHAVED DATA: EXPERIENCE OF THE NINDS t-PA STROKE TRIAL

G. Chase, Mei Lu, Shuhui Li, 2001 .

Effects of tissue plasminogen activator for acute ischemic stroke at one year

Joseph P. Broderick, Barbara C. Tilley, J. Broderick, 1999 .

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

J. Grotta, M. Kaste, W. Hacke, 2004, The Lancet.

Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial

J. Grotta, K. Welch, T. Brott, 2001, Stroke.

Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.

Joseph P. Broderick, Scott Hamilton, Suresh C. Patel, 2005, Annals of emergency medicine.

A40 Analytical issues for Stroke clinical trials

B. Tilley, Mei Lu, 1996 .

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

Scott Hamilton, Suresh Patel, Joseph P Broderick, 2004, The Lancet.

Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial

J. Grotta, J. Broderick, J. Marler, 2000, Stroke.

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

J. Grotta, J. Broderick, J. Marler, 2001, Annals of neurology.

A Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Preliminary Reliability and Validity

P D Lyden, J. Broderick, T. Brott, 2001, Stroke.

Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

K. Welch, S. Levine, B. Tilley, 1997, Archives of neurology.

Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t‐PA stroke trial

B. Tilley, Mei Lu, M. Lu, 2001, Statistics in medicine.

Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

P D Lyden, M Frankel, D. Tanné, 1999, Stroke.

Hypertension and its treatment in the NINDS rt-PA Stroke Trial.

J. Grotta, J. Broderick, J. Marler, 1998, Stroke.

Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators.

J. Marler, R. Kothari, T. Brott, 1999, Stroke.

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.

N L Geller, T Brott, J. Grotta, 1996, Stroke.

Predicting prognosis after stroke

J. Broderick, B. Tilley, T. Brott, 2000, Neurology.

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

J. Grotta, K. Welch, S. Levine, 2001, JAMA.

The Next Step Trial: impact of a worksite colorectal cancer screening promotion program.

K. Glanz, A. Kristal, B. Tilley, 1999, Preventive medicine.

Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research

Joseph P. Broderick, Scott Hamilton, Patrick D. Lyden, 2005, Journal of Neuroscience Methods.

Planning The Next Step

K. Glanz, S. Vernon, Mei Lu, 1995 .